Bone cancer can start in any bone in the body, but most commonly affects the pelvis or the long bones of the arms and legs. Bone cancer is rare and accounts for less than 1 percent of all cancers. In fact, non-cancerous bone tumors are much more common than cancerous tumors. Sarcoma, bone cancer treatment in Hyderabad
The term “bone cancer” does not include cancers that start elsewhere in the body and spread (metastasize) to the bone. Instead, these cancers are named for their origin, such as breast cancer that has metastasized to the bones.
The signs and symptoms of bone cancer include:
- Bone pain
- Swelling and tenderness near the affected area
- Weakened bone that leads to breakage
- Involuntary weight loss
The cause of most types of bone cancer is unknown. A small number of bone cancers have been linked to hereditary factors, while others have been linked to previous radiation exposure.
Types of bone cancer
- Osteosarcoma Open the popup dialog
- Bone cancer is divided into different types depending on the type of cell in which the cancer started. The most common types of bone cancer are:
Osteosarcoma. Osteosarcoma is the most common type of bone cancer. In this tumor, cancer cells form bones. This type of bone cancer most commonly occurs in the bones of the leg or arm in children and young adults. In rare cases, osteosarcomas can occur outside the bones (extrasceletal osteosarcomas). Sarcoma, bone cancer treatment in Hyderabad
It’s not clear what causes bone cancer, but doctors have found that certain factors are associated with an increased risk, including:
- Hereditary genetic syndromes. Some rare genetic syndromes passed down from families increase the risk of developing bone cancer, including Li Fraumeni syndrome and inherited retinoblastoma. Sarcoma, bone cancer treatment in Hyderabad
- Paget’s disease of the bone. Most common in the elderly, Paget’s disease of the bone can increase the risk of developing bone cancer later.
- Radiation therapy for cancer. Exposure to high doses of radiation, such as those given during radiation therapy for cancer, increases the risk of bone cancer in the future.